Clinical Trial Update: The Renal Safety in Patients With Chronic HCV Undergoing Sofosbuvir Containing Antiviral Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining renal safety in patients with chronic HCV treated with sofosbuvir-containing antiviral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Kidney Disease

Drugs mentioned

• Sofosbuvir-containing antiviral therapy (sofosbuvir)

Snippet

Sponsor: MTI University | Conditions: Egyptian Patients, HCV Treatment, Kidney Function | Phase 4 | Status: UNKNOWN